Literature DB >> 17556197

Exclusion of multiple candidate genes and large genomic rearrangements in SCN5A in a Dutch Brugada syndrome cohort.

Tamara T Koopmann1, Leander Beekman, Marielle Alders, Paola G Meregalli, Marcel M A M Mannens, Antoon F M Moorman, Arthur A M Wilde, Connie R Bezzina.   

Abstract

BACKGROUND: The Brugada syndrome is an inherited cardiac electrical disorder associated with a high incidence of life-threatening arrhythmias. Screening for mutations in the cardiac Na+ channel-encoding gene SCN5A uncovers a mutation in approximately 20% of Brugada syndrome cases. Genetic heterogeneity and/or undetected SCN5A mutations, such as exon duplications and deletions, could be involved in the remaining 80% mutation-negative patients.
OBJECTIVES: Thirty-eight SCN5A mutation-negative Dutch Brugada syndrome probands were studied. The SCN5A gene was investigated for exon duplication and deletion, and a number of candidate genes (Caveolin-3, Irx-3, Irx-4, Irx-5, Irx-6, Plakoglobin, Plakophilin-2, SCN1B, SCN2B, SCN3B, and SCN4B) were tested for the occurrence of point mutations and small insertions/deletions.
METHODS: We used a quantitative multiplex approach to determine SCN5A exon copy numbers. Mutation analysis of the candidate genes was performed by direct sequencing of polymerase chain reaction-amplified coding regions.
RESULTS: No large genomic rearrangements in SCN5A were identified. No mutations were found in the candidate genes. Twenty novel polymorphisms were identified in these genes.
CONCLUSION: Large genomic rearrangements in SCN5A are not a common cause of Brugada syndrome. Similarly, the studied candidate genes are unlikely to be major causal genes of Brugada syndrome. Further studies are required to identify other genes responsible for this syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556197     DOI: 10.1016/j.hrthm.2007.02.021

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  20 in total

1.  Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing.

Authors:  David J Tester; Amber J Benton; Laura Train; Barbara Deal; Linnea M Baudhuin; Michael J Ackerman
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

2.  Genetic basis of Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-03-23       Impact factor: 6.343

3.  Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.

Authors:  Barry London; Michael Michalec; Haider Mehdi; Xiaodong Zhu; Laurie Kerchner; Shamarendra Sanyal; Prakash C Viswanathan; Arnold E Pfahnl; Lijuan L Shang; Mohan Madhusudanan; Catherine J Baty; Stephen Lagana; Ryan Aleong; Rebecca Gutmann; Michael J Ackerman; Dennis M McNamara; Raul Weiss; Samuel C Dudley
Journal:  Circulation       Date:  2007-10-29       Impact factor: 29.690

Review 4.  Relationship Between Arrhythmogenic Right Ventricular Cardiomyopathy and Brugada Syndrome: New Insights From Molecular Biology and Clinical Implications.

Authors:  Domenico Corrado; Alessandro Zorzi; Marina Cerrone; Ilaria Rigato; Marco Mongillo; Barbara Bauce; Mario Delmar
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-04

5.  TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations.

Authors:  Berivan Baskin; Jon R Skinner; Shubhayan Sanatani; Deborah Terespolsky; Andrew D Krahn; Peter N Ray; Stephen W Scherer; Robert M Hamilton
Journal:  Hum Genet       Date:  2013-06-29       Impact factor: 4.132

6.  Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.

Authors:  Hiroshi Watanabe; Tamara T Koopmann; Solena Le Scouarnec; Tao Yang; Christiana R Ingram; Jean-Jacques Schott; Sophie Demolombe; Vincent Probst; Frédéric Anselme; Denis Escande; Ans C P Wiesfeld; Arne Pfeufer; Stefan Kääb; H-Erich Wichmann; Can Hasdemir; Yoshifusa Aizawa; Arthur A M Wilde; Dan M Roden; Connie R Bezzina
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

7.  Diagnostic dilemmas: overlapping features of brugada syndrome and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mark G Hoogendijk
Journal:  Front Physiol       Date:  2012-05-23       Impact factor: 4.566

8.  Comprehensive Genetic Characterization of a Spanish Brugada Syndrome Cohort.

Authors:  Elisabet Selga; Oscar Campuzano; Mel Lina Pinsach-Abuin; Alexandra Pérez-Serra; Irene Mademont-Soler; Helena Riuró; Ferran Picó; Mònica Coll; Anna Iglesias; Sara Pagans; Georgia Sarquella-Brugada; Paola Berne; Begoña Benito; Josep Brugada; José M Porres; Matilde López Zea; Víctor Castro-Urda; Ignacio Fernández-Lozano; Ramon Brugada
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

9.  An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Shohei Kataoka; Naoki Serizawa; Kazutaka Kitamura; Atsushi Suzuki; Tsuyoshi Suzuki; Tsuyoshi Shiga; Morio Shoda; Nobuhisa Hagiwara
Journal:  J Arrhythm       Date:  2015-11-30

10.  Large Genomic Imbalances in Brugada Syndrome.

Authors:  Irene Mademont-Soler; Mel Lina Pinsach-Abuin; Helena Riuró; Jesus Mates; Alexandra Pérez-Serra; Mònica Coll; José Manuel Porres; Bernat Del Olmo; Anna Iglesias; Elisabet Selga; Ferran Picó; Sara Pagans; Carles Ferrer-Costa; Geòrgia Sarquella-Brugada; Elena Arbelo; Sergi Cesar; Josep Brugada; Óscar Campuzano; Ramon Brugada
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.